This Tweet is currently unavailable. It might be loading or has been removed.
Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
。爱思助手下载最新版本对此有专业解读
Foreign minister says 272 Ghanaians are thought to have been drawn into battle since 2022, after he visited Kyiv
[새로 나왔어요]수학자가 알려주는 증명의 함정 外